H. Schrezenmeier

发表

Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma.

H. Heimpel, H. Schrezenmeier, B. Hertenstein, 1995, Blood.

Mesenchymal stem cells for clinical application

M. Krampera, P. Bourin, H. Schrezenmeier, 2010, Vox sanguinis.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.

P. Meusers, H. Heimpel, F. Herrmann, 1991, The New England journal of medicine.

Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells

S. Wiese, M. Port, M. Rojewski, 2023, Cells.

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.

I. Scheffrahn, S. Morris, J. Duyster, 1999, Experimental hematology.

Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry

J W Lee, J. Szer, R. Brodsky, 2016, Internal medicine journal.

Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria

H. Audebert, H. Schrezenmeier, R. Haberl, 2005, Journal of Neurology.

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

C. Schumann, M. Taupitz, W. Hofmann, 2012, Annals of Hematology.

Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.

V. Rasche, K. Landfester, N. Fekete, 2014, Contrast media & molecular imaging.

The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia

F. Locatelli, F. Locatelli, H. Schrezenmeier, 2007, Bone Marrow Transplantation.

Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test

W. Flegel, I. von Zabern, H. Schrezenmeier, 2012, Vox sanguinis.

Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men.

J. Born, L. Marshall, H. Fehm, 1998, The Journal of clinical endocrinology and metabolism.

T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells

H. Schrezenmeier, B. Fleischer, H. Schrezenmeier, 1988, The Journal of experimental medicine.

Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany.

D. Strunk, H. Mertsching, H. Northoff, 2009, Cytotherapy.

Mesenchymal stem cells for clinical application

M. Krampera, P. Bourin, L. Sensébé, 2010, Vox sanguinis.

T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures.

H. Schrezenmeier, B. Fleischer, P. Conradt, 1989, Cellular immunology.

Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab)

H. Schrezenmeier, A. Risitano, H. Schrezenmeier, 2013, Bone Marrow Transplantation.

A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage

A. Schambach, H. Kestler, L. Zender, 2012, Cell.

Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.

J. Born, S. Drechsler, S. Bornstein, 1994, The Journal of clinical endocrinology and metabolism.

Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.

V. Rasche, K. Landfester, N. Fekete, 2014, Contrast media & molecular imaging.

Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.

H. Schrezenmeier, B. Fleischer, S. Thomé, 1993, Experimental hematology.

Donor selection and release criteria of cellular therapy products

D. Strunk, P. Rebulla, H. Bönig, 2013, Vox sanguinis.

A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.

H. Heimpel, H. Schrezenmeier, B. Hertenstein, 1995, Experimental hematology.

Deficiency of innate and acquired immunity caused by an IKBKB mutation.

U. Pannicke, K. Schwarz, S. Ehl, 2013, The New England journal of medicine.

Inactivation of a T cell receptor-associated GTP-binding protein by antibody-induced modulation of the T cell receptor/CD3 complex

H. Schrezenmeier, G. Ahnert-Hilger, B. Fleischer, 1988, The Journal of experimental medicine.

Inactivation of a T Cell Receptor-associated Gtp-binding Protein by Antibodyinduced Modulation of the T Cell Receptor/cd3 Complex Brief Definitive Report

H. Schrezenmeier, Bernhard Fleischer, Gudrun Ahnerthilger, 1988 .

Circulating Erythropoietin Levels in Pathophysiological Conditions a

H. Schrezenmeier, B. Kubanek, I. Rich, 1994, Annals of the New York Academy of Sciences.

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

A. Tichelli, P. Ljungman, M. Henry-Amar, 1999, Annals of internal medicine.

Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy

L. Bullinger, K. Döhner, H. Döhner, 2014, Leukemia.

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

P. Ljungman, H. Schrezenmeier, E. Gluckman, 1993, British journal of haematology.

High levels of thrombopoietin in sera of patients with essential thrombocythemia: Cause or consequence of abnormal platelet production?

H. Heimpel, M. Griesshammer, H. Schrezenmeier, 1998, Annals of Hematology.